Showing results (31-40 of 492) with videos related to
Sort By:
Pageof 50
Schizophrenia Bulletin|April 18, 2016
Mortality Risk Associated With Long-acting Injectable Antipsychotics: A Systematic Review and Meta-analyses of Randomized Controlled TrialsTaro Kishi, Shinji Matsunaga, Nakao IwataNeuropsychiatric Disease and Treatment|December 10, 2015
Memantine for the treatment of frontotemporal dementia: a meta-analysisTaro Kishi, Shinji Matsunaga, Nakao IwataNeuropsychiatric Disease and Treatment|November 23, 2018
Memantine treatment for Japanese patients with moderate to severe Alzheimer's disease: a meta-analysis of double-blind, randomized, placebo-controlled trialsTaro Kishi, Shinji Matsunaga, Nakao IwataJournal of Alzheimer'S Disease : JAD|February 4, 2017
Combination Therapy with Zonisamide and Antiparkinson Drugs for Parkinson's Disease: A Meta-AnalysisShinji Matsunaga, Taro Kishi, Nakao IwataJournal of Alzheimer'S Disease : JAD|June 6, 2018
Combination Therapy of Serotonin Reuptake Inhibitors and Memantine for Obsessive- Compulsive Disorder: A Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled TrialsTaro Kishi, Yuki Matsuda, Nakao IwataJournal of Psychiatric Research|August 1, 2015
Intramuscular olanzapine for agitated patients: A systematic review and meta-analysis of randomized controlled trialsTaro Kishi, Shinji Matsunaga, Nakao IwataThe American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|January 11, 2014
Memantine for Lewy body disorders: systematic review and meta-analysisShinji Matsunaga, Taro Kishi, Nakao IwataThe International Journal of Neuropsychopharmacology|April 5, 2013
Augmentation of antipsychotic drug action by azapirone 5-HT1A receptor partial agonists: a meta-analysisTaro Kishi, Herbert Y Meltzer, Nakao IwataNeuropsychiatric Disease and Treatment|December 20, 2014
Iminodibenzyl class antipsychotics for schizophrenia: a systematic review and meta-analysis of carpipramine, clocapramine, and mosapramineTaro Kishi, Shinji Matsunaga, Yuki Matsuda, et al.Neuromolecular Medicine|July 31, 2013
Selective serotonin 3 receptor antagonist treatment for schizophrenia: meta-analysis and systematic reviewTaro Kishi, Tomohiko Mukai, Yuki Matsuda, et al.Pageof 50